Total Payments
$10,328
2024 Payments
$902.39
Companies
45
Transactions
799
Medicare Patients
23,222
Medicare Billing
$1.0M
Payment Breakdown by Category
Food & Beverage$10,262 (99.4%)
Education$47.39 (0.5%)
Other$18.80 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,262 | 793 | 99.4% |
| Education | $47.39 | 5 | 0.5% |
| Debt forgiveness | $18.80 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,667 | 142 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,378 | 55 | $0 (2024) |
| Novo Nordisk Inc | $1,076 | 120 | $0 (2024) |
| Allergan, Inc. | $894.83 | 86 | $0 (2020) |
| PFIZER INC. | $763.87 | 58 | $0 (2024) |
| GlaxoSmithKline, LLC. | $554.30 | 51 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $524.17 | 38 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $437.89 | 41 | $0 (2023) |
| Amgen Inc. | $436.67 | 30 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $315.36 | 25 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $902.39 | 62 | ABBVIE INC. ($255.51) |
| 2023 | $1,543 | 90 | AbbVie Inc. ($499.13) |
| 2022 | $1,156 | 97 | ABBVIE INC. ($358.98) |
| 2021 | $1,357 | 97 | AbbVie Inc. ($528.45) |
| 2020 | $1,391 | 121 | Allergan, Inc. ($391.84) |
| 2019 | $1,331 | 118 | Novo Nordisk Inc ($241.55) |
| 2018 | $1,233 | 95 | Janssen Pharmaceuticals, Inc ($254.83) |
| 2017 | $1,416 | 119 | Allergan Inc. ($296.74) |
All Payment Transactions
799 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/01/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/31/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $4.87 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.56 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.04 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: PAIN | ||||||
| 09/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/11/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/29/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $13.32 | General |
| Category: NEUROLOGY | ||||||
| 08/29/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.69 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/27/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $4.20 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Diabetes | ||||||
| 08/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.29 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.10 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/01/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $25.71 | General |
| Category: NEUROLOGY | ||||||
| 07/26/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $4.88 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 46 | 6,200 | 9,372 | $615,441 | $269,130 |
| 2022 | 52 | 6,253 | 9,331 | $609,268 | $264,402 |
| 2021 | 50 | 5,939 | 8,808 | $596,941 | $230,772 |
| 2020 | 40 | 4,830 | 7,199 | $551,742 | $244,458 |
Total Patients
23,222
Total Services
34,710
Medicare Billing
$1.0M
Procedure Codes
188
All Medicare Procedures & Services
188 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 451 | 451 | $106,436 | $56,502 | 53.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 163 | 1,188 | $89,100 | $50,948 | 57.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 393 | 608 | $60,800 | $34,133 | 56.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 84 | 84 | $27,300 | $23,344 | 85.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 63 | 63 | $17,892 | $10,118 | 56.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 137 | 140 | $11,140 | $9,958 | 89.4% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 500 | 555 | $34,965 | $9,120 | 26.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 506 | 1,002 | $10,020 | $8,392 | 83.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 461 | 523 | $27,196 | $6,770 | 24.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 560 | 644 | $54,740 | $6,626 | 12.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 73 | 77 | $11,858 | $6,400 | 54.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 34 | 34 | $9,656 | $5,311 | 55.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 500 | 636 | $19,080 | $4,821 | 25.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 143 | 147 | $4,410 | $4,322 | 98.0% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 55 | 110 | $11,550 | $3,206 | 27.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 199 | 305 | $11,590 | $2,870 | 24.8% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 147 | 147 | $11,760 | $2,762 | 23.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 82 | 82 | $2,460 | $2,411 | 98.0% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 527 | 629 | $12,580 | $1,926 | 15.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 43 | 46 | $3,082 | $1,767 | 57.3% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 97 | 104 | $7,800 | $1,537 | 19.7% |
| 82306 | Vitamin d-3 level | Office | 2023 | 46 | 48 | $6,576 | $1,392 | 21.2% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 59 | 66 | $4,950 | $1,376 | 27.8% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 95 | 103 | $3,914 | $1,376 | 35.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 72 | 152 | $6,080 | $1,346 | 22.1% |
About Dr. Shawn Stussy, MD
Dr. Shawn Stussy, MD is a Family Medicine healthcare provider based in Wake Village, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/06/2005. The National Provider Identifier (NPI) number assigned to this provider is 1821082835.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shawn Stussy, MD has received a total of $10,328 in payments from pharmaceutical and medical device companies, with $902.39 received in 2024. These payments were reported across 799 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($10,262).
As a Medicare-enrolled provider, Stussy has provided services to 23,222 Medicare beneficiaries, totaling 34,710 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 188 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Wake Village, TX
- Active Since 09/06/2005
- Last Updated 06/13/2014
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1821082835
Products in Payments
- XARELTO (Drug) $1,264
- VRAYLAR (Drug) $934.81
- UBRELVY (Drug) $787.99
- Ozempic (Drug) $513.59
- ELIQUIS (Drug) $471.40
- QULIPTA (Drug) $401.91
- TROKENDI XR (Drug) $393.62
- ENTRESTO (Drug) $306.32
- FARXIGA (Drug) $262.16
- TRELEGY ELLIPTA (Drug) $240.90
- Victoza (Drug) $239.19
- TOUJEO (Drug) $197.25
- LINZESS (Drug) $175.37
- VOQUEZNA (Drug) $153.22
- LEQVIO (Drug) $152.40
- ANORO (Drug) $151.06
- Tresiba (Drug) $149.48
- Aimovig (Biological) $135.29
- Xofluza (Drug) $133.28
- BELSOMRA (Drug) $114.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.